
Asia Pacific Master Patient Index Software Market
No. of Pages: 93 | Report Code: TIPRE00023499 | Category: Technology, Media and Telecommunications
No. of Pages: 93 | Report Code: TIPRE00023499 | Category: Technology, Media and Telecommunications
Master patient index (MPI) is an essential as well as critical part of every hospital or a healthcare facility center. To maintain the huge database of patients’ MPI software or systems are used. MPI software or system is a primary feature build in the electronic health record (HER) to maintain a universal identity of patients at the organizational level. MPI helps in connecting patient records from several databases and reduces data duplication of patients. MPI also helps avoiding inaccuracy of data resulting in improper treatments.
Thus, the adoption of cloud-based technologies is expected to create a significant demand for master patient index software in the coming years, which is further anticipated to drive the master patient index software market.
The COVID-19 pandemic has put a major strain on the health systems of many countries around the world. Testing capacity in many Asia Pacific countries was limited and of low quality in the initial days of the pandemic, which led to a surge in the COVID-19 cases. However, many countries, such as South Korea, Japan, and Singapore, were efficiently contained the situation through robust tracking and testing. Also, India has the second-highest number of cases in the world after the US. The increasing burden on existing healthcare systems and rising demand for advanced data collection and analysis technologies are expected to drive the Asia Pacific Master Patient index software market, even during the pandemic. In January 2021, BC Platforms, a significant clinical and genomic data management player, announced a collaboration with Japan-based RIKEN research institution and the Finnish Institute for Health and Welfare (‘THL’). Moreover, adoption of digitalization of the healthcare system, the growing preference for remote patient care in the developing countries in the region, and a more significant number of regulatory agencies laying stress on value and patient outcome, patient engagement is expected to increase adoption of the master patient index software in coming years.
Strategic insights for the Asia Pacific Master Patient Index Software provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.
Report Attribute | Details |
---|---|
Market size in 2021 | US$ 180.3 Million |
Market Size by 2028 | US$ 371.2 Million |
Global CAGR (2021 - 2028) | 10.9% |
Historical Data | 2019-2020 |
Forecast period | 2022-2028 |
Segments Covered |
By Type
|
Regions and Countries Covered | Asia-Pacific
|
Market leaders and key company profiles |
The geographic scope of the Asia Pacific Master Patient Index Software refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.
The Master patient index software market in Asia Pacific is expected to grow from US$ 180.3 million in 2021 to US$ 371.2 million by 2028; it is estimated to grow at a CAGR of 10.9% from 2021 to 2028. A significant shift toward paperless data management has enabled various healthcare players to adopt cloud-based technologies. Also, decrease in the cost of cloud-based technologies, improvements in terms of flexibility and security, and low maintenance requirements and costs are further propelling the adoption of these technologies among healthcare organizations. These advantages help the provide high-quality services and personal care to patients. The cloud-based technologies have eliminated interoperability issues, and at the same time have enabled the easy data integration with a healthcare organization. As the healthcare data, available in huge volumes, are organized and saved on cloud servers, processing these data has become feasible for the healthcare professionals. Cloud-based technologies allow healthcare professionals to operate in tandem with different departments, institutions, and healthcare service providers and consumers. Furthermore, technological advancements are supporting the integration of artificial intelligence (AI) and machine learning in patient management, which assist users to manage healthcare operations and massive data. Thus, the adoption of cloud-based technologies boosts the demand for master patient index software to streamline and simplify the patient data management process.
In terms of type, the software segment accounted for the largest share of the Asia Pacific master patient index software market in 2020. In terms of deployment, the cloud-based segment held a larger market share of the master patient index software market in 2020.
A few major primary and secondary sources referred to for preparing this report on the master patient index software market in Asia Pacific are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are McKESSON CORPORATION, Oracle Corporation, Wipro Limited, Allscripts Healthcare Solutions, Inc., MEDITECH, and Intersystems Corporation.
By Type
By Deployment
By Country
The Asia Pacific Master Patient Index Software Market is valued at US$ 180.3 Million in 2021, it is projected to reach US$ 371.2 Million by 2028.
As per our report Asia Pacific Master Patient Index Software Market, the market size is valued at US$ 180.3 Million in 2021, projecting it to reach US$ 371.2 Million by 2028. This translates to a CAGR of approximately 10.9% during the forecast period.
The Asia Pacific Master Patient Index Software Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Master Patient Index Software Market report:
The Asia Pacific Master Patient Index Software Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Asia Pacific Master Patient Index Software Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Asia Pacific Master Patient Index Software Market value chain can benefit from the information contained in a comprehensive market report.